Abstract:Introduction The endoscopic endonasal approach (EEA) is a safe and effective treatment for pituitary adenomas (PAs). Since extracapsular resection (ER) of PAs improves tumor resection and endocrine remission rates, the interface between the pseudocapsule and gland draws increasing attention. However, it is difficult to precisely dissect the tumor along the exact boundary, and complete removal of the tumor increases the risks of normal tissue damage and cerebrospinal fluid (CSF) leakage. In this study, we investigated the extracapsular resection as well as the pseudocapsule histology to evaluate the effectiveness and safety of pseudocapsule-related surgical interventions. Methods From December 2017 to December 2019, 189 patients of PAs via EEA in our single center were analyzed retrospectively. The images, operative details, and clinical follow-up of patients were collected. Sixty-four patients underwent pseudocapsule-based ER, and 125 patients also underwent traditional intracapsular resection (IR) with or without intensive excision for FPAs. The clinical characteristics, tumor resection, endocrinological outcomes, and postoperative morbidities of the two groups were compared. Informed consent for publication of our article was obtained from each patient. Histological examination of pseudocapsule was performed using hematoxylin and eosin and reticulin staining. Results The gross total recession was 62 (96.9%) in the ER group and 107 (85.6%) cases in the IR group, whereas the endocrine remission rate was 29/31 (93.5%) and 40/53 (75.5%) cases, respectively. Anterior pituitary functions were not aggravated postoperatively in any patient, but transient diabetes insipidus (DI) occurred more in the IR group (64.0%) than in ER (48.4%). Pseudocapsule specimens were obtained in 93 patients, and clusters of small cell aggregation were detected in 11 pseudocapsule specimens (11.8%) whereas other patients showed no remarkable developed pseudocapsule. Intraoperative CSF leak occurred more in the ER group (28.1%) than in the IR group (13.6%), but no difference was seen between two groups postoperatively. No case of intracranial hematoma or pituitary crisis occurred in both groups. After a mean follow-up of 22.8 months, tumor recurrence was observed in 4 (2.1%) cases. Conclusion Pseudocapsule-based extracapsular resection of PAs via EEA is an effective and safe procedure to achieve complete resection with high and sustained endocrine remission and without deteriorating pituitary function.

Extra-pseudocapsule Dissection Technique in Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas

Improvement in the Quality of Early Postoperative Course after Endoscopic Transsphenoidal Pituitary Surgery: Description of Surgical Technique and Outcome

Time to Revive the Value of the Pseudocapsule in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone Adenomas.

Endoscopic-assisted Transsphenoidal Approach for the Resection of Pituitary Adenoma

Endoscopic Transnasal Transsphenoidal Surgery for Pituitary Adenoma

Pseudocapsule-Based Resection for Pituitary Adenomas via the Endoscopic Endonasal Approach

Postoperative Complications of Endoscopic Transsphenoidal Pituitary Adenoma Resection

Endoscope-Assisted Supraorbital Keyhole Approach for the Resection of Benign Tumors of the Sellar Region

Endoscopic Endonasal Pituitary Adenomas Surgery: the Surgical Experience of 178 Consecutive Patients and Learning Curve of Two Neurosurgeons

Extended Transsphenoidal Approach for the Removal of Invasive Pituitary Adenoma(117 Cases Analysis)

Endoscopic endonasal pituitary adenomas surgery for 138 consecutive patients

The Surgical Strategy and Technique of Direct Endonasal Transsphenoidal Approach for Removal of Pituitar Adenoma Apoplexy

Extended Transsphenoidal Approach for Pituitary Adenomas Invading the Anterior Cranial Base, Cavernous Sinus, and Clivus: a Single-Center Experience with 126 Consecutive Cases

Protective Strategies for Pituitary Function During Endoscopic Transnasal Pituitary Adenoma Surgery: A Single-center Experience

Endoscopic Endonasal Transsphenoidal Surgery for Treating Pituitary Adenoma Via a Sub-Septum Mucosa Approach.

Neuroendoscopic microsurgical treatment of pituitary adenomas using bilateral endonasal approach with fixed arm

Transsphenoidal pseudocapsule based extracapsular resection of functioning pituitary adenomas

Direct transsphenoidal pituitary adenoma resection under endoscope

Resection of Pituitary Adenoma by Unilateral Endonasal Transsphenoidal Approach Microsurgery

Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center

Treatment of pituitary adenomas with a transsphenoidal approach.